Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Two series of histamine H4 antagonists prepared and tested at Janssen

April 28, 2004

Sinapultide equivalent to poractant alfa in the prevention of RDS

April 28, 2004

Preclinical results for MDI-P in asthma

April 27, 2004

Advair approved for children aged 4-11 years

April 27, 2004

BioMarin to acquire Medicis' pediatric business

April 23, 2004

Two series of HNE inhibitors prepared and tested by Bayer scientists

April 23, 2004

Phase II trial under way for R-112 in allergic rhinitis

April 22, 2004

Seretide Diskus submitted for Japanese approval

April 21, 2004

AstraZeneca claims MMP-12 inhibitors with utility in asthma and COPD therapy

April 21, 2004

INO-4995 shows potency in cystic fibrosis mouse NPD model

April 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...